Home » Topics » Analysis and data insight, BioWorld MedTech

Analysis and data insight, BioWorld MedTech
RSS

Med-tech gainers and losers for Dec. 4-8, 2023

Dec. 11, 2023

No Comments

The top 10 med-tech stock gainers and losers for the week.

Med-tech financings November 2023

Med-tech financings mark YOY decline, November sees more than $1B raised

Dec. 8, 2023

By Amanda Lanier

No Comments

Med-tech financings surpassed $1 billion again in November, with transactions totalling $1.02 billion for the month. Though a decline from the $1.23 billion raised in October, the value is up from September’s $645.75 million.

Med-tech gainers and losers for Nov. 27-Dec. 1, 2023

Dec. 4, 2023

No Comments

The top 10 med-tech stock gainers and losers for the week.

Med-tech gainers and losers for Nov. 20-24, 2023

Nov. 27, 2023

No Comments

The top 10 med-tech stock gainers and losers for the week.

Med-tech gainers and losers for Nov. 13-17, 2023

Nov. 20, 2023

No Comments

The top 10 med-tech stock gainers and losers for the week.

Med-tech gainers and losers for Nov. 6-10, 2023

Nov. 13, 2023

No Comments

The top 10 med-tech stock gainers and losers for the week.

Med-tech deals October 2023

Med-tech M&As continue decline while deal value soars nearly 50% YOY

Nov. 10, 2023

By Amanda Lanier

No Comments

While med-tech deals were well below average the past two months, cumulative values are up 47.67% over the same period last year. Through October, the total worth of med-tech deals reached $9.97 billion, rising from $6.75 billion in the corresponding period in 2022.

Med-tech gainers and losers for Oct. 30-Nov. 3, 2023

Nov. 6, 2023

No Comments

The top 10 med-tech stock gainers and losers for the week.

Med-tech financings October 2023

Up from September low, med-tech financings down nearly 42% for the year

Nov. 3, 2023

By Amanda Lanier

No Comments

Med-tech saw some good news in October, with total financings value reaching $1.22 billion, an increase of 89.23% from the $645.75 million in September. However, the increase didn’t make up for the broader year-over-year decline in med-tech investments.

Med-tech gainers and losers for Oct. 23-27, 2023

Oct. 30, 2023

No Comments

The top 10 med-tech stock gainers and losers for the week.

Today's news in brief
BioWorld
BioWorld briefs for Dec. 3, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 3, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
Radiopharma Telix acquires FAP-targeting agents for bladder cancer
BioWorld
Radiopharmaceutical company Telix Pharmaceuticals Ltd. has inked a deal worth up to AU$264 million (US$171 million) to license and develop next-generation...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Analysis and data insight, BioWorld MedTech RSS

Analysis and data insight, BioWorld MedTech
RSS